SCHEDULE 13D/A: Broadwood Capital Increases Stake in STAAR Surgical to Over 27%

Broadwood Capital and its affiliates have further increased their beneficial ownership in STAAR Surgical Company, now holding 27.1% of outstanding common stock, through recent open market purchases.

Summary

• Broadwood Partners, L.P., Broadwood Capital, Inc., and Neal C. Bradsher (collectively, the "Reporting Persons") have filed an Amendment No. 34 to Schedule 13D regarding their ownership in STAAR Surgical Company.
• As of the filing date, the Reporting Persons beneficially own a combined 13,358,164 shares of STAAR Surgical's Common Stock, representing 27.1% of the 49,325,372 shares outstanding.
• Broadwood Partners and Broadwood Capital each beneficially own 13,332,264 shares, constituting 27.0% of the outstanding shares.
• Neal C. Bradsher beneficially owns 13,358,164 shares, representing 27.1% of the outstanding shares, which includes 25,900 shares over which he has sole voting and dispositive power, and 13,332,264 shares over which he has shared voting and dispositive power.
• The funds for the share purchases primarily came from Broadwood Partners' working capital and Mr. Bradsher's personal funds, with no borrowed funds used for the purchases other than for ordinary course working capital.
• The purpose of the transaction remains consistent with previous filings, with no material change to the Item 4 disclosure from the Schedule 13D/A filed on April 2, 2025.
• Recent purchases by the Reporting Persons include: 209,535 shares on April 3, 2025, at a weighted average price of $16.9668; 492,631 shares on April 4, 2025, at $15.9042; 5,000 shares on April 4, 2025, at $16.4579; 126,465 shares on April 7, 2025, at $15.5772; and 11,589 shares on April 7, 2025, at $15.9810.

Sentiment

Score: 7

Explanation: The increased beneficial ownership by Broadwood Capital and its affiliates, reaching over 27% of STAAR Surgical Company, suggests strong conviction from a major investor. This can be interpreted positively by the market as it may signal belief in the company's future prospects or potential for strategic changes that could unlock shareholder value.

Positives

• A significant increase in beneficial ownership by an investment group, indicating strong conviction in the company's value.
• The purchases were funded by working capital and personal funds, not borrowed funds, suggesting financial stability of the investor.

Future Outlook

The document does not provide forward-looking statements or guidance from STAAR Surgical Company. It primarily details the beneficial ownership and recent transactions of the Reporting Persons.

Industry Context

This Schedule 13D filing reflects a significant increase in ownership by an activist investment group in STAAR Surgical Company. While the document does not provide broader industry analysis, such an increased stake by a major investor often signals a belief in the company's long-term potential or an intent to influence strategic direction within its industry.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry benchmarks, comparable companies, projects, or results. It focuses solely on the ownership stake and transactions of the Reporting Persons in STAAR Surgical Company.

Corporate Governance

Legal Proceedings

• The Reporting Persons have stated that they have not been convicted in any criminal proceeding (excluding traffic violations) or been a party to any civil proceeding subject to judgment, decree, or final order related to federal or state securities laws in the last five years.

Related Party Transactions

• The document does not disclose any related party dealings beyond the joint filing agreement among the Reporting Persons.

Stakeholder Impact

• Shareholders: The increased stake by a significant investor could be viewed positively, potentially signaling confidence in the company's value or future strategic initiatives.
• Management: A large, activist investor's increased stake may lead to increased engagement or pressure on management regarding strategic direction or operational performance.

Key Dates

Keywords

STAAR Surgical Company, Broadwood Capital, Broadwood Partners, Neal C. Bradsher, Schedule 13D, Beneficial Ownership, Common Stock, Investment Adviser, Activist Investor, Equity Stake, SEC Filing